Tushar Jani, Group Chairman, Cargo Service Center said, “I believe 70 – 75 percentage of generic drugs today are exported to the Europe and US from India. I think that’s very critical. Our pharma manufacturing industry has been doing a fantastic job and getting regular FDA approvals from the US Drug administrators, during inspection. Today you go to any pharmacy abroad you will find many Indian generic drugs. The important factor is if this development enables us to build cross border pharma e-commerce capabilities out of India. As a company, our vision now is to develop pharma e-commerce capabilities and increase our world share. Around 31 % of depression drug is in fact transported from India to US. If we develop the capability of giving pharma e-commerce services, the world would recognize us and that’s what’s needed. Domestic pharma industry would also benefit greatly from this vision. We have to develop our skills for product delivery to Europe and US in a most controlled manner. We need to immediately take action on temperature excursions at any point in supply chain and also need to have infrastructure controlled by us on the destination. In my company our workers are being trained about variety of drugs being loaded/ off loaded. We need to have a robust supply from starting point to the destination. That’s where investment is needed from the Indian service providers to give good reliable pharma to the world.”